167 related articles for article (PubMed ID: 36918802)
1. Comprehensive analysis of the biological function and immune infiltration of SLC38A2 in gastric cancer.
Zhu L; Wang Z; Han W; Xu A
BMC Gastroenterol; 2023 Mar; 23(1):74. PubMed ID: 36918802
[TBL] [Abstract][Full Text] [Related]
2. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
Zhu H; Wang G; Zhu H; Xu A
J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
[No Abstract] [Full Text] [Related]
3. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
Front Immunol; 2022; 13():922138. PubMed ID: 36090985
[TBL] [Abstract][Full Text] [Related]
4. Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.
Zhu H; Jiang W; Zhu H; Hu J; Tang B; Zhou Z; He X
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35315496
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
Cheng A; Guo X; Dai X; Wang Z
FEBS Open Bio; 2021 Jun; 11(6):1785-1798. PubMed ID: 33837660
[TBL] [Abstract][Full Text] [Related]
6. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
Wang M; Li C; Liu Y; Wang Z
Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
[TBL] [Abstract][Full Text] [Related]
7. High expression of GPR176 predicts poor prognosis of gastric cancer patients and promotes the proliferation, migration, and invasion of gastric cancer cells.
Zhang Y; Gu X; Zhu F; Li Y; Huang Y; Ju S
Sci Rep; 2023 Jun; 13(1):9360. PubMed ID: 37291181
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.
Liu X; Wei X; Niu W; Wang D; Wang B; Zhuang H
Mol Med Rep; 2018 Nov; 18(5):4356-4364. PubMed ID: 30221666
[TBL] [Abstract][Full Text] [Related]
9. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Liu B; Xiao X; Lin Z; Lou Y; Zhao L
Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
[TBL] [Abstract][Full Text] [Related]
10. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
11. Prediction and verification of the prognostic biomarker
Zhang W; Zhou D; Song S; Hong X; Xu Y; Wu Y; Li S; Zeng S; Huang Y; Chen X; Liang Y; Guo S; Pan H; Li H
Oncol Lett; 2024 Feb; 27(2):70. PubMed ID: 38192676
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
[TBL] [Abstract][Full Text] [Related]
14. LCP1 is a prognostic biomarker correlated with immune infiltrates in gastric cancer.
Zeng Q; Li L; Feng Z; Luo L; Xiong J; Jie Z; Cao Y; Li Z
Cancer Biomark; 2021; 30(1):105-125. PubMed ID: 32986657
[TBL] [Abstract][Full Text] [Related]
15. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
[TBL] [Abstract][Full Text] [Related]
16. Cancer-suppressing miR-520-3p gene inhibits proliferation, migration, and invasion of gastric cancer cells through targeted regulation of KLF7.
Jiang W; Yang W; Liu J; Zhao X; Lu W
Bull Cancer; 2022 Jun; 109(6):631-641. PubMed ID: 35465967
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition.
Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H
Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484
[TBL] [Abstract][Full Text] [Related]
18. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
19. Bioinformatic analysis of the role of solute carrier-glutamine transporters in breast cancer.
Zhao X; Jin L; Liu Y; Liu Z; Liu Q
Ann Transl Med; 2022 Jul; 10(14):777. PubMed ID: 35965834
[TBL] [Abstract][Full Text] [Related]
20. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]